GlaxoSmithKline AG - Bexsero, Injektionssuspension
65730
01
Bexsero
Injektionssuspension
J07AH09
Meningococcus B, Multicomponent Vaccine
23.11.2017
Composition
proteinum fusionatum NHBA neisseriae meningitidis B 50 µg, proteinum NadA neisseriae meningitidis B 50 µg, proteinum fusionatum fHbp neisseriae meningitidis B 50 µg, vesicula membranae exterioris (OMV) ex Neisseria meningitidis B (Stamm: NZ98/254) 25 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, histidinum, natrii chloridum, saccharum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.2 mg.
Packungsbestandteile
Suspension injectable
Principe actif
Concentr.
Proteinum Fusionatum fhbp Neisseriae Meningitidis B
50µg / 0.5ml
Proteinum Fusionatum nhba Neisseriae Meningitidis B
50µg / 0.5ml
Proteinum nada Neisseriae Meningitidis B
50µg / 0.5ml
Vesicula Membranae Exterioris (Omv) ex Neisseria Meningitidis b (Stamm: Nz98/254)
25µg / 0.5ml
BAG: Principe actif
Concentr.
Neisseria Meningitidis b Outer Membrane Vesicle
25 mcg
Proteinum Fusionatum fhbp Neisserii Meningitidii B
50 mcg
Proteinum Fusionatum nhba Neisserii Meningitidii B
